Sio Gene Therapies Inc. Quarterly Income Tax Expense (Benefit) in USD from Q4 2014 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Sio Gene Therapies Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2014 to Q4 2022.
  • Sio Gene Therapies Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $0.000.
  • Sio Gene Therapies Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $283K, a 342% increase year-over-year.
  • Sio Gene Therapies Inc. annual Income Tax Expense (Benefit) for 2021 was $259K.
  • Sio Gene Therapies Inc. annual Income Tax Expense (Benefit) for 2020 was -$212K, a 148% decline from 2019.
  • Sio Gene Therapies Inc. annual Income Tax Expense (Benefit) for 2019 was $438K, a 229% increase from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $283K $0 $0 Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $283K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $283K -$4K +$24K +85.7% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $259K $287K +$195K +212% Jan 1, 2022 Mar 31, 2022 10-K 2022-06-14
Q4 2021 $64K $0 +$188K Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$124K $0 +$146K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$270K -$28K -$58K -193% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$212K $92K -$190K -67.4% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-14
Q4 2020 -$22K -$188K -$179K -1989% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q3 2020 $157K -$146K -$273K -215% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $430K $30K -$8K -21.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $438K $282K +$373K Jan 1, 2020 Mar 31, 2020 10-K 2021-06-09
Q4 2019 $65K -$9K -$61K -117% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $126K $127K +$33K +35.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $93K $38K -$40K -51.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $133K -$91K -$59K -184% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-10
Q4 2018 $192K $52K +$28K +117% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 $164K $94K +$1.68M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$1.52M $78K -$2.44M -96.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $921K -$32K +$1.74M +98.2% Jan 1, 2018 Mar 31, 2018 10-K 2019-06-11
Q4 2017 -$823K $24K +$185K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 -$1.01M -$1.59M -$2.32M -318% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $1.31M $2.52M +$2.37M +1602% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$1.06M -$1.78M -$859K -93.7% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-11
Q4 2016 -$201K -$161K -$963K -120% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $762K $729K +$705K +2938% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $57K $148K +$74K +100% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$17K -$917K Jan 1, 2016 Mar 31, 2016 10-K 2018-06-11
Q4 2015 $802K +$802K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 $24K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $74K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q4 2014 $0 Nov 1, 2014 Dec 31, 2014 10-Q 2016-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.